Article PDF
References
Maillard LC . Action des acides aminés sur les sucres: formation des melaniodines par voie méthodique. C R Acad Sci 1912;154:66–8.
Cohen MR Diabetes and protein glycosylation. Berlin: Springer-Verlag, 1986.
Higgins PJ, Bunn HF . Kinetic analysis of the nonenzymatic glycosylation of haemoglobin. J Biol Chem 1981;256:5204–8.
Baynes JW, Thorpe SR, Murtiashaw MH . Nonenzymatic glycosylation of lysine residues in albumin. Methods Enzymol 1984;106:88–98.
Bunn HF, Haney DN, Kamin S, Gabbay KH, Gallop PM . The biosynthesis of human haemoglobin Alc. J Clin Invest 1976;57:1652–9.
Bunn HF, Higgins PJ . Reaction of monosaccharides with proteins: possible evolutionary significance. Science 1981;213:222–4.
Angyal SJ . The composition of reducing sugars in solution. In: Harmon RE, editor. Asymmetry in carbohydrates. New York:Dekker, 1979:15–30.
Kunkel HG, Wallenius G . New haemoglobin in normal adult blood. Science 1955;122:–288.
Holmquist WR, Schroeder WA . A new N-terminal blocking group involving a Schiff base in haemoglobin Alc. Biochemistry 1966;5:2489–503.
Brownlee M, Vlassara H, Cerami A . Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984;101:527–37.
Day JF, Thorpe SR, Baynes JW . Nonenzymatically glucosy-lated albumin. J Biol Chem 1979;254:595–7.
Dolhoffer R, Wieland OH . Glycosylation of serum albumin: elevated glycosyl-albumin in diabetic patients. FEBS Lett 1979;103:282–6.
Dolhoffer R, Wieland OH . Increased glycosylation of serum albumin in diabetes mellitus. Diabetes 1980;29:417–22.
Shaklai N, Garlick RL, Bunn HF . Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem 1984;259:3812–7.
Mereish KA, Rosenberg H, Cobby J . Glucosylated albumin and its influence on salicylate binding. J Pharm Sci 1982;71:235–8.
Kemp SF, Kearns GL, Turley CP . Alteration of phenytoin binding by glycosylation of albumin in IDDM. Diabetes 1987;36:505–9.
Murtiashaw MH, Winterhalter KH . Non-enzymatic glyca-tion of human albumin does not alter its palmitate binding. Diabetologia 1986;29:366–70.
Mangili R, Viberti GC, Vergani D . Antibodies to human albumin epitopes in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1988;31:639–46.
Danze PM, Tarjoman A, Rousseaux J, Fossati P, Dautrevaux M . Evidence for an increased glycation of IgG in diabetic patients. Clin Chim Acta 1987;166:143–53.
Kaneshige H . Nonenzymatic glycosylation of serum IgG and its effect on antibody activity in patients with diabetes mellitus. Diabetes 1987;36:822–8.
Morin LG, Austin GE, Burkhalter A . Nonenzymatic glycation of immunoglobulin does not impair antigen—antibody binding. Clin Chem 1987;33:692–4.
Morin LG, Austin GE, Rodey GE, Johnson JE . Nonenzymatic glycation of human immunoglobulins does not impair their immunoreactivity. Clin Chem 1989;35:1039–42.
Lutjens A, te Velde AA, vd Veen EA, vd Meer J . Glycosylation of human fibrinogen in vivo. Diabetologia 1985;28:87–9.
Sampietro T, Lenzi S, Cecchetti P, Giampietro O, Crushelli L, Navalesi R . Nonenzymatic glycation of human platelet membrane proteins in vitro and in vivo. Clin Chem 1986;32:1328–31.
Cohen I, Burk D, Fullerton RJ, Veis A, Green D . Nonenzymatic glycation of human blood platelet proteins. Thromb Res 1989;55:341–9.
Yarat A, Emelki N . The effect of non-enzymatically glyco-sylated collagen on normal human platelets. Clin Chim Acta 1989;185:203–6.
Ceriello A, Marchchi E, Barbanti M, Milani MR, Giugliano D, Quatraro A, Lefebvre P . Nonenzymatic glycation reduces heparin cofactor II anti-thrombin activity. Diabetologia 1990;33:205–7.
Mamo JCL, Szeto L, Steiner G . Glycation of very low density lipoprotein from rat plasma impairs its catabolism. Diabetologia 1990;33:339–45.
Duell PB, Oram JF, Bierman EL . Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux. Diabetes 1991;40:377–84.
Kortlandt W, Benschop C, van Rijn HJM, Erkelens DW . Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus. Diabetologia 1992;35:202–7.
Kortlandt W, Benschop C, Erkelens DW, Thijssen JHH . A simple method for the measurement of total and glycated apolipoprotein B and its relevance to apolipoprotein-B metabolism in diabetes mellitus. Clin Chim Acta 1989;186:109–18.
Dominiczak MH . The significance of the products of the Maillard (browning) reaction in diabetes. Diabetic Med 1991;8:505–16.
Pongor S, Ulrich PC, Bencsath FA, Cerami A . Ageing of proteins: isolation and identification of a fluorescent chro-mophore from the reaction of polypeptides with glucose. Proc Natl Acad Sci USA 1984;81:2684–8.
Chang JCF, Ulrich PC, Bucala R, Cerami A . Detection of an advanced glycosylation product bound to protein in situ. J Biol Chem 1985;260:7970–4.
Njoroge FG, Fernandes AA, Monnier VM . Mechanism of formation of the putative advanced glycosylation end product and protein cross-link 2-(2-furoyl)-4(5)-(2-fura-nyl-l)-imidazole. J Biol Chem 1988;263:10646–52.
Lapolla A, Gerhardinger C, Pelli B, Sturaro A, Favero ED, Traldi P, et al. Absence of brown product FFI in nondiabetic and diabetic rat collagen. Diabetes 1990;39:57–61.
Sell DR, Monnier VM . Isolation, purification and partial characterisation of novel fluorophores from ageing human insoluble collagen-rich tissue. Connect Tissue Res 1989;19:77–92.
Sell DR, Monnier VM . Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 1989;264:21597–602.
Sell DR, Monnier VM . End-stage renal disease and diabetes catalyse the formation of a pentose-derived cross-link from ageing human collagen. J Clin Invest 1990;85:380–4.
Lyons TJ, Bailie KE, Dyer DG, Dunn JA, Baynes JW . Decrease in skin collagen glycation with improved glycaemic control in patients with insulin dependent diabetes mellitus. J Clin Invest 1991;87:1910–5.
Baynes JW . Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405–12.
Cerami A, Vlassara H, Brownlee M . Role of advanced glycosylation products in complications of diabetes. Diabetes Care 1988;11(Suppl 1):73–9.
Wolff SP, Jiang ZY, Hunt JV . Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radical Biol Med 1991;10:339–52.
Hunt JV, Wolff SP . Is glucose the sole source of tissue browning in diabetes mellitus? FEBS Lett 1990;269:258–60.
Jones AF, Jennings PE, Wakefield A, Winkles J, Lunec J, Barnett AH . Collagen-linked fluorescence in diabetes mellitus. N Engl J Med 1986;315:323–4.
Jones AF, Jennings PE, Wakefield A, Winkles JW, Lunec J, Barnett AH . Protein browning and diabetic complications. Lancet 1986;2:459.
Kawamura N, Ookawara T, Suzuki K, Konishi K, Mino M, Taniguchi N . Increased glycated Cu,Zn-superoxide dis-mutase levels in erythrocytes of patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1992;74:1352–4.
Ahmed MU, Thorpe SR, Baynes JW . Identification of N-car-boxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986;261:4889–94.
Knecht KJ, Dunn JA, McFarland KF, McCance DR, Lyons TJ, Thorpe SR, Baynes JW . Effect of diabetes and ageing on carboxymethyllysine levels in human urine. Diabetes 1991;40:190–6.
Jones AF, Jennings PE, Wakefield A, Winkles JW, Lunec J, Barnett AH . The fluorescence of protein in diabetic patients with or without retinopathy. Diabetic Med 1988;5:547–51.
Le Guen CA, Bain S, Barnett AH, Lunec J . Captopril inhibits fluorescence development in nonenzymatically glycosylated proteins. In: Martin SM, Halloran SP, editors. Proceedings of the national meeting of the Association of Clinical Biochemists, p 42.
Bagchi D, Prasad R, Das DK . Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor. Biochem Biophys Res Commun 1989;158:52–7.
Liang JN, Hershorin LL, Chylack LT . Nonenzymatic glyco-sylation in human diabetic lens crystallins. Diabetologia 1986;29:225–8.
Stevens VJ, Rouzer CA, Monnier VM, Cerami A . Diabetic cataract formation: potential role of glycosylation of lens crystallins. Proc Natl Acad Sci USA 1978;75:2918–22.
Srivistava SK, Ansari NH, Bhatnagar A, Hair G, Liu S, Das B . Activation of aldose reductase by nonenzymatic glycosylation. In: Baynes JW, Monnier VM, editors. The Maillard reaction in ageing, diabetes, and nutrition. New York: Liss, 1989:171–84.
Paisey R, Hopton M, Hartog M . Correlation between skin glycosylation and glycaemic control in human diabetes. Clin Endocrinol 1984;20:521–5.
Paisey R, Clamp JR, Kent MJC, Light ND, Hopton M, Hartog M . Glycosylation of hair: possible measure of chronic hyperglycaemia. BMJ 1984;288:669–71.
Bakan E, Bakan N . Glycosylation of nail in diabetics: possible marker of long-term hyperglycaemia. Clin Chim Acta 1985;147:1–5.
Vlassara H, Brownlee M, Cerami A . Nonenzymic glycosylation of peripheral nerve protein in diabetes mellitus. Proc Natl Acad Sci USA 1981;78:5190–2.
Vlassara H, Brownlee M, Cerami A . Excessive nonenzymic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 1983;32:670–4.
Cohen MP, Urdanivia E, Surma M, Ciborowski J . Nonenzymic glycosylation of basement membranes. Diabetes 1981;30:367–71.
Schnider SL, Kohn RR . Glucosylation of human collagen in ageing and diabetes mellitus. J Clin Invest 1980;66:1179–81.
Schnider SL, Kohn RR . Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen. J Clin Invest 1981;67:1630–5.
Nishimoto S, Oimomi M, Baba S . Glycation of collagen in the aorta and the development of ageing. Clin Chim Acta 1989;182:235–7.
Garlick RL, Bunn HF, Spiro RG . Nonenzymatic glycation of basement membranes from human glomeruli and bovine sources. Diabetes 1988;37:1144–50.
Reiser KM . Nonenzymatic glycation of collagen in ageing and diabetes. Proc Soc Exp Biol Med 1990;196:17–29.
Reiser KM, Amigable M . Site specific glycosylation of collagen under hyperglycaemic conditions in vivo and in vitro. Diabetes 1990;39(Suppl 1):28A.
Cohen MP, Uradanivia E, Surma M, Wu VY . Increased glycosylation of glomerular basement membrane collagen in diabetes. Biochem Biophys Res Commun 1980;95:765–9.
Vishwanath V, Frank KE, Elmets CA, Dauchot PJ, Monnier VM . Glycation of skin collagen in type 1 diabetes mellitus. Diabetes 1986;35:916–21.
Baynes JW, Watkins NG, Fisher CI, Hull CJ, Patrick JS, Ahmed MU, et al. The Amadori product on protein: structure and reactions. In: Baynes JW, Monnier VM, editors. The Maillard reaction in ageing, diabetes, and nutrition. New York: Liss, 1989:43–68.
Schuh J, Fairclough GF, Haschemeyer RH . Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc Natl Acad Sci USA 1978;75:3173–7.
Rathi AN, Padmavathi S, Chadrakasan G . Influence of monosaccharides on the fibrillogenesis of type 1 collagen. Biochem Med Metabolic Biol 1989;42:209–15.
Tsilibary EC, Charonis AS, Furcht LT . Changes of the main collagenous NCl domain of type IV collagen after in vitro non-enzymatic glucosylation. Diabetes 1987;36(Suppl 1):85A.
Bassiouny AR, Rosenberg H, McDonald TL . Glucosylated collagen is antigenic. Diabetes 1983;32:1182–4.
Tarsio JF, Reger LA, Furcht LT . Decreased interaction of fibronectin, type IV collagen, and heparin due to nonenzymatic glycation: implications for diabetes mellitus. Biochemistry 1987;26:1014–20.
Brownlee M, Pongor S, Cerami A . Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. J Exp Med 1983;158:1739–44.
Monnier VM, Kohn RR, Cerami A . Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 1984;81:583–7.
Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR . Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986;314:403–8.
Kohn RR, Cerami A, Monnier VM . Collagen ageing in vitro by nonenzymatic glycosylation and browning. Diabetes 1984;33:57–9.
Makita Z, Radoff S, Rayfield E, Cerami A, Friedman E, Vlassara H . Radioreceptor assay (RRA) for human serum and arterial tissue advanced glycosylation end products (AGE). Diabetes 1990;39(Suppl 1):29A.
Makita Z, Radoff S, Rayfield E, Yang Z, Skolnik E, Delaney V, et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991;325:836–42.
Radoff S, Makita Z, Vlassara H . Radioreceptor assay for advanced glycosylation end products. Diabetes 1991;40:1731–8.
Brownlee M, Cerami A, Vlassara H . Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 1988;4:437–51.
Vlassara H, Brownlee M, Cerami A . Advanced non-enzymatic tissue glycosylation: significance in late diabetic complications. Diabetes Res Clin Pract 1989;7:S103–S108.
Brownlee M . Glycosylation products as toxic mediators of diabetic complications. Annu Rev Med 1991;42:159–66.
Brownlee M, Cerami A, Vlassara H . Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315–21.
Bucala R, Tracey KJ, Cerami A . Advanced glycosylation products quench nitric oxide and mediate defective endo-thelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991;87:432–8.
Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A . Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986;232:1629–32.
Brownlee M, Vlassara H, Cerami A . Aminoguanidine prevents hyperglycaemia-induced defect in binding of heparin by matrix molecules. Diabetes 1987;36(Suppl 1):85A.
Hammes HP, Marchtin S, Federlin K, Geisen K, Brownlee M . Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Diabetes 1990;39(Suppl 1):62A.
Nicholls K, Mandel TE . Advanced glycosylation end-products in experimental murine diabetic nephropathy. Lab Invest 1989;60:486–91.
Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums L . Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 1991;40:1328–34.
Oxlund H, Andreassen TT . Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus. Diabetologia 1992;35:19–25.
Ellis EN, Bowen W . Aminoguanidine ameliorates glomer-ular basement membrane (GBM) thickening in experimental diabetes. Diabetes 1990;39(Suppl 1):71A.
Khatami M, Suldan Z, David I, Li W, Rockey JH . Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation. Life Sci 1988;43:1725–31.
Requena JR . The main mechanism of action of aminoguanidine. Diabetologia 1991;34(Suppl 1):A162.
Le Guen CA, Jones AF, Barnett AH, Lunec J . Role of reactive oxygen species in the generation of fluorescence by glycation. Ann Clin Biochem 1992;29:184–9.
Greene DA, Lattimer SA . Biochemical alterations and complications in diabetes. Clin Chem 1986;32:B42–B47.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
John, W., Lamb, E. The maillard or browning reaction in diabetes. Eye 7, 230–237 (1993). https://doi.org/10.1038/eye.1993.55
Issue Date:
DOI: https://doi.org/10.1038/eye.1993.55
Keywords
This article is cited by
-
Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS
Reproductive Biology and Endocrinology (2016)
-
Advanced glycation End-products (AGEs): an emerging concern for processed food industries
Journal of Food Science and Technology (2015)
-
Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy
Heart Failure Reviews (2014)